Correlation Between Dicerna Pharmaceuticals and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Dicerna Pharmaceuticals and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dicerna Pharmaceuticals and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dicerna Pharmaceuticals and Editas Medicine, you can compare the effects of market volatilities on Dicerna Pharmaceuticals and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dicerna Pharmaceuticals with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dicerna Pharmaceuticals and Editas Medicine.
Diversification Opportunities for Dicerna Pharmaceuticals and Editas Medicine
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dicerna and Editas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dicerna Pharmaceuticals and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Dicerna Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dicerna Pharmaceuticals are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Dicerna Pharmaceuticals i.e., Dicerna Pharmaceuticals and Editas Medicine go up and down completely randomly.
Pair Corralation between Dicerna Pharmaceuticals and Editas Medicine
If you would invest (100.00) in Dicerna Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 100.00 from holding Dicerna Pharmaceuticals or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Dicerna Pharmaceuticals vs. Editas Medicine
Performance |
| Timeline |
| Dicerna Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Editas Medicine |
Dicerna Pharmaceuticals and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dicerna Pharmaceuticals and Editas Medicine
The main advantage of trading using opposite Dicerna Pharmaceuticals and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dicerna Pharmaceuticals position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Dicerna Pharmaceuticals vs. Viemed Healthcare | Dicerna Pharmaceuticals vs. Boston Omaha Corp | Dicerna Pharmaceuticals vs. 51Talk Online Education | Dicerna Pharmaceuticals vs. Integral Ad Science |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |